Cardinal Health dba Specialty Pharmaceutical Services recalls

FDA enforcement reports naming Cardinal Health dba Specialty Pharmaceutical Services as the recalling firm.

Recall reports: 1
Class I (serious): 0
Most recent report: Oct 2, 2019

Severity

Oct 2, 2019Nucala (mepolizumab) Injection, 100 mg/mL Prefilled Syringe, Single-Dose, For subcutane…Drug · Cardinal Health dba Specialty Pharmaceutical ServicesTemperature Abuse; Product stored and shipped outside of labeled storage requirements.Class II